GlassScriptPhysician profile
Janet Lee
NPI 1003813932
$5,280.51
in general payments reported to CMS, 2019-2025
25 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 83% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,636 · 2020: $459 · 2021: $60.07 · 2022: $209 · 2023: $357 · 2024: $497 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,916.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $2,207.40 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $474.81 | 2019-2024 | Dupixent |
| Optinose US, INC. | $388.53 | 2019-2025 | |
| Glaxosmithkline, LLC. | $354.06 | 2024-2025 | Nucala |
| Kaleo, INC. | $203.03 | 2019-2023 | Auvi-Q |
| Stryker Corporation | $196.73 | 2019 | |
| Acclarent, INC | $194.42 | 2019-2023 | Trudi Nav Cable |
| Genzyme Corporation | $173.69 | 2021-2025 | |
| Depuy Synthes Sales INC. | $147.41 | 2025 | Matrixmandible |
| Abbvie INC. | $133.60 | 2025 | |
| Allergan, INC. | $130.97 | 2019 | |
| Pfizer INC. | $121.44 | 2024-2025 | |
| Intersect Ent, INC. | $97.81 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $83.31 | 2025 | Neffy |
| Medtronic USA, INC. | $73.24 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $57.57 | 2023 | |
| Itamar Medical INC | $47.10 | 2025 | Watchpatone |
| Amgen INC. | $41.54 | 2023-2025 | Tavneos, Tezspire |
| Alexion Pharmaceuticals, INC. | $35.00 | 2025 | Ultomiris |
| Bausch & Lomb Americas INC. | $21.94 | 2024 | Vyzulta, Zylet, Prolensa |
| Medtronic, INC. | $21.85 | 2024 | Propel |
| Alk-Abello, INC | $21.10 | 2020 | |
| Integra Lifesciences Corporation | $19.03 | 2023 | Integra Duo, Instruments-Orthopedic, Codman Isocool Aht |
| Merck Sharp & Dohme LLC | $17.66 | 2023 | |
| Aerin Medical INC. | $17.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.